FDA Adverse Event Injury Summary report: N

NV GXL LINR, NTRL, 28MM ID, GROUP 1 CUPS

MDR report key: 20430707 · Received October 11, 2024

Report

Report Number
1038671-2024-03952
Event Type
Injury
Date Received
October 11, 2024
Date of Event
October 11, 2024
Report Date
February 6, 2025
Manufacturer
EXACTECH, INC.
Product Code
JDI
UDI-DI
10885862022066
PMA / PMN Number
K070479
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

CONCOMITANTS: (B)(6) 186-01-48 - INTEGRIP CC, CLUSTER 48MM, G1 (B)(6) 186-01-50 - INTEGRIP CC, CLUSTER 50MM, G1 (B)(6) 180-65-30 - ALTEON 6.5MM SCREW, 30MM (B)(6) 180-65-30 - ALTEON 6.5MM SCREW, 30MM (B)(6) 190-30-03 - ALT HA S CLR STD SZ 3 (B)(6) 190-30-03 - ALT HA S CLR STD SZ 3 (B)(6) 170-28-00 - BIOLOX DELTA FEMORAL HEAD 28MM OD, +0MM (B)(6) 170-28-00 - BIOLOX DELTA FEMORAL HEAD 28MM OD, +0MM. THE PRODUCT ASSOCIATED WITH THE REPORTED EVENT IS WITHIN THE SCOPE OF RECALL Z-1729-2022. HOWEVER, THERE IS INSUFFICIENT INFORMATION TO EVALUATE WHETHER THE SUBJECT ISSUE OF THE RECALL WAS A CAUSE OR CONTRIBUTOR TO THE REPORTED EVENT. THE DEVICE WAS NOT RETURNED FOR EVALUATION AND NO MEDICAL OR OTHER RECORDS CONTAINING TREATMENT INFORMATION OR PATIENT INFORMATION HAVE BEEN RECEIVED; THEREFORE, THE REPORTED EVENT CANNOT BE CONFIRMED, NOR CAN THE CIRCUMSTANCES OR POTENTIAL CAUSES OR CONTRIBUTORS TO THE ALLEGED EVENT BE EVALUATED. SHOULD ADDITIONAL, MATERIAL INFORMATION BECOME AVAILABLE THAT PERMITS MORE ANALYSIS OR CONCLUSIONS, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Additional Manufacturer Narrative · 0

BASED ON THE AVAILABLE INFORMATION, THE PATIENT MEETS THE FOLLOWING RISK CRITERIA FOR EARLY PROSTHESIS WEAR AND/OR OSTEOLYSIS: IMPLANTED WITH A LATERALIZED LINER, COMBINATION OF LARGEST AVAILABLE FEMORAL HEAD AND/OR THINNEST AVAILABLE ACETABULAR LINER WAS USED AND IMPLANTED WITH A COMPONENT HAVING A SHELF AGE OF GREATER THAN 2 YEARS. THE MOST LIKELY CAUSE FOR THE REPORTED REVISION DUE TO PROSTHESIS WEAR AND OSTEOLYSIS MAY HAVE BEEN A COMBINATION OF RISK FACTORS SUCH AS USE ERROR, IMPLANT POSITIONING, IMPLANT SIZE SELECTION, AND PATIENT FACTORS (FITNESS FOR SURGERY, BIOMECHANICS, ACTIVITY LEVEL AND LOCAL TISSUE OXIDATION POTENTIAL). HOWEVER, THIS CANNOT BE CONFIRMED AS THE DEVICES WERE NOT RETURNED FOR EVALUATION, AND IMAGES AND RADIOGRAPHS WERE NOT PROVIDED. H6: CORRECTED HEALTH EFFECT CLINICAL CODES.

Description of Event or Problem · 0

LEGAL CASE ¿ USA (MDL NO. 3044). (B)(4) LH IS ASSOCIATED WITH THIS CASE. IT WAS REPORTED VIA LEGAL DOCUMENTATION THAT APPROXIMATELY 52 MONTHS AFTER A RIGHT TOTAL HIP REPLACEMENT PROCEDURE, THE PATIENT HAS EXPERIENCED PROSTHESIS WEAR, PAIN, STIFFNESS, AMBULATORY PROBLEMS, JOINT PAIN AND WEAKNESS, OSTEOLYSIS, PAST AND FUTURE MEDICAL EXPENSES, PAST AND FUTURE LOST WAGES, LOSS OF EARNING CAPACITY, MENTAL SUFFERING AND ANGUISH, PAIN AND SUFFERING. NO FURTHER ISSUES OR COMPLICATIONS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE. UNABLE TO CONFIRM SPECIFIC DEVICES DUE TO BILATERAL EBI INVOICE DATA. THE SERIAL NUMBER (B)(6) ARE CONFIRMED TO BE A PART OF RECALL NUMBER: Z-1729-2022.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
294406 NV GXL LINR, NTRL, 28MM ID, GROUP 1 CUPS PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED JDI EXACTECH, INC. 10885862022066

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown SEE H11.